Invasive Group B Streptococcal Disease in Two Pediatric Patients with Systemic Lupus Erythematosus
Author(s) -
Dongning Wu,
Kenneth Bromberg,
Roberto Jodorkovsky
Publication year - 2013
Publication title -
case reports in pediatrics
Language(s) - English
Resource type - Journals
eISSN - 2090-6803
pISSN - 2090-6811
DOI - 10.1155/2013/896014
Subject(s) - medicine , group b , streptococcus , disease , group a , immunology , streptococcal infections , systemic lupus erythematosus , streptococcus agalactiae , dermatology , genetics , bacteria , biology
Systemic lupus erythematosus (SLE) is an autoimmune disease associated with high morbidity and mortality, often caused by infection. We report two patients with SLE who were treated with steroids and immunosuppressive medication and then developed invasive Group B Streptococcus (GBS) infections. While GBS infection is rare in the nonneonatal pediatric age group, GBS should be considered when treating SLE patients presenting with signs of infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom